Adamantane-Monoterpenoid Conjugates Linked via Heterocyclic Linkers Enhance the Cytotoxic Effect of Topotecan.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 May 2022
Historique:
received: 29 04 2022
revised: 15 05 2022
accepted: 22 05 2022
entrez: 10 6 2022
pubmed: 11 6 2022
medline: 14 6 2022
Statut: epublish

Résumé

Inhibiting tyrosyl-DNA phosphodiesterase 1 (TDP1) is a promising strategy for increasing the effectiveness of existing antitumor therapy since it can remove the DNA lesions caused by anticancer drugs, which form covalent complexes with topoisomerase 1 (TOP1). Here, new adamantane-monoterpene conjugates with a 1,2,4-triazole or 1,3,4-thiadiazole linker core were synthesized, where (+)-and (-)-campholenic and (+)-camphor derivatives were used as monoterpene fragments. The campholenic derivatives

Identifiants

pubmed: 35684313
pii: molecules27113374
doi: 10.3390/molecules27113374
pmc: PMC9182348
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Monoterpenes 0
Phosphodiesterase Inhibitors 0
Camphor 76-22-2
Topotecan 7M7YKX2N15
Phosphoric Diester Hydrolases EC 3.1.4.-
Adamantane PJY633525U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Russian Science Foundation
ID : 19-13-00040

Références

Bioorg Med Chem. 2015 May 1;23(9):2044-52
pubmed: 25819333
Nat Rev Cancer. 2009 May;9(5):327-37
pubmed: 19377505
Chem Sci. 2021 Jan 28;12(11):3876-3884
pubmed: 34163656
EMBO J. 2009 Dec 2;28(23):3667-80
pubmed: 19851285
Proteins. 2005 Nov 1;61(2):272-87
pubmed: 16106379
Mol Inform. 2012 Dec;31(11-12):847-55
pubmed: 27476738
Mol Cancer Ther. 2015 Feb;14(2):575-85
pubmed: 25522766
Nucleic Acids Res. 2014 Apr;42(7):4435-49
pubmed: 24493735
J Nat Prod. 2020 Aug 28;83(8):2320-2329
pubmed: 32786885
Int J Mol Sci. 2021 Oct 20;22(21):
pubmed: 34768766
Molecules. 2021 Mar 30;26(7):
pubmed: 33808389
Eur J Med Chem. 2019 Jan 1;161:581-593
pubmed: 30396105
Bioorg Med Chem. 2018 Aug 15;26(15):4470-4480
pubmed: 30076000
Invest New Drugs. 2021 Apr;39(2):362-376
pubmed: 32981006
Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12009-14
pubmed: 11572945
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
J Org Chem. 2018 Nov 2;83(21):12951-12964
pubmed: 30200759
Drug Metab Rev. 2014 Nov;46(4):494-507
pubmed: 25327705
Molecules. 2019 Oct 15;24(20):
pubmed: 31619021
Oncol Ther. 2021 Dec;9(2):541-556
pubmed: 34159519
Anticancer Agents Med Chem. 2019;19(4):463-472
pubmed: 30523770
Mol Inform. 2019 Mar;38(3):e1800068
pubmed: 30345657
Eur J Med Chem. 2019 Jun 1;171:129-168
pubmed: 30917303
J Chem Inf Model. 2009 Jan;49(1):84-96
pubmed: 19125657
J Mol Biol. 1997 Apr 4;267(3):727-48
pubmed: 9126849
Molecules. 2021 May 24;26(11):
pubmed: 34073771
Bioorg Med Chem. 2016 Nov 1;24(21):5573-5581
pubmed: 27658793
Clin Exp Metastasis. 2021 Oct;38(5):431-440
pubmed: 34370156
Nat Rev Mol Cell Biol. 2002 Jun;3(6):430-40
pubmed: 12042765
Mar Drugs. 2022 Mar 17;20(3):
pubmed: 35323510
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
pubmed: 10592235
J Am Chem Soc. 2009 Aug 26;131(33):11998-2006
pubmed: 19653649
J Biol Chem. 2004 Dec 31;279(53):55618-25
pubmed: 15494395
J Comput Aided Mol Des. 1997 Sep;11(5):425-45
pubmed: 9385547
J Nat Prod. 2016 Nov 23;79(11):2961-2967
pubmed: 27933897
Proteins. 2003 Sep 1;52(4):609-23
pubmed: 12910460
Bioorg Chem. 2022 Jun;123:105789
pubmed: 35429714
EMBO J. 2007 Nov 14;26(22):4720-31
pubmed: 17914460
Acta Crystallogr C Struct Chem. 2015 Jan;71(Pt 1):3-8
pubmed: 25567568
Bioorg Chem. 2018 Feb;76:392-399
pubmed: 29248742
Nucleic Acids Res. 2007;35(13):4474-84
pubmed: 17576665
Steroids. 2021 Jan;165:108771
pubmed: 33221302
Int J Mol Sci. 2019 Dec 23;21(1):
pubmed: 31878088
J Med Chem. 2012 Oct 25;55(20):8671-84
pubmed: 23006064
Biochim Biophys Acta. 1998 Oct 1;1400(1-3):83-105
pubmed: 9748515
Biomolecules. 2021 Jul 01;11(7):
pubmed: 34356597
Biosens Bioelectron. 2013 Oct 15;48:230-7
pubmed: 23693093

Auteurs

Aldar A Munkuev (AA)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Nadezhda S Dyrkheeva (NS)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Tatyana E Kornienko (TE)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Ekaterina S Ilina (ES)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Dmitry I Ivankin (DI)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Evgeniy V Suslov (EV)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Dina V Korchagina (DV)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Yuriy V Gatilov (YV)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Alexandra L Zakharenko (AL)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Anastasia A Malakhova (AA)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Federal Research Centre Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.

Jóhannes Reynisson (J)

School of Pharmacy and Bioengineering, Keele University, Hornbeam Building, Newcastle-under-Lyme, Staffordshire ST5 5BG, UK.

Konstantin P Volcho (KP)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Nariman F Salakhutdinov (NF)

N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia.

Olga I Lavrik (OI)

Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 630090 Novosibirsk, Russia.
Department of Physical and Chemical Biology and Biotechnology, Altai State University, Pr. Lenina 61, 656049 Barnaul, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs
Humans Male Female Health Knowledge, Attitudes, Practice Middle Aged
Humans Female Alopecia Breast Neoplasms Middle Aged
Neoplastic Stem Cells Animals Humans Aldehyde Dehydrogenase Tretinoin

Classifications MeSH